assessing gingivitis of 3 different dentifrices compared to a negative control.

Conditions: Gingivitis

Summary: the primary objective of this study is to evaluate the effect of two experimental hops extract-containing dentifrices on gingivitis relative to a positive control 0.454% snf2 dentifrice and a negative control dentifrice after 12 weeks of product use.


Eligibility criteria:
inclusion criteria: * be at least 18 years of age; * provide written informed consent prior to participation and be given a signed copy of the informed consent form; * be in general good health as determined by the investigator based on a review of the health history/update for participation in the trial; if female of child-bearing potential, agree to use a medically approved method of birth control for the duration of the study. acceptable methods of medically approved birth control include: at least 3 months of use of a hormonal birth control (including oral contraceptives, hormone birth control patch, vaginal contraceptive ring, injectable contraceptives, or hormone implant), double-barrier method, intrauterine devices, non-heterosexual lifestyle or agrees to use contraception if planning on changing to heterosexual partner(s), vasectomy of partner at least 6 months prior to screening. not applicable to females not of child-bearing potential (females who have undergone a sterilization procedure including hysterectomy, bilateral oophorectomy, bilateral tubal ligation, complete endometrial ablation) or have been post-menopausal for at least 1 year prior; * if female and of child-bearing potential, agree to immediately inform the study investigator if they become pregnant; * have at least 20 gradable teeth; * have mild to moderate gingivitis with a range of 10 to 70% bleeding sites; * agree to return for scheduled visits and follow the study procedures; * agree to refrain from use of any non-study oral hygiene products for the duration of the study; regular floss users can continue to floss in their customary manner. * agree to delay any elective dentistry, including dental prophylaxis, until the completion of the study; and * agree to refrain from any oral hygiene the morning of each visit. exclusion criteria: * having taken antibiotic, anti-inflammatory, or anticoagulant medications within 4 weeks of the baseline visit; * having any oral conditions that could interfere with study compliance and/or examination procedures, such as widespread caries, soft or hard tissue tumor of the oral cavity, severe gingivitis, or advanced periodontal disease; * females of child-bearing potential who are not using a medically approved method of birth control (i.e., hormonal contraceptives including oral contraceptives, hormone birth control patch, vaginal contraceptive ring, injectable contraceptives, or hormone implant, double-barrier method, intrauterine devices, non-heterosexual lifestyle or agrees to use contraception if planning on changing to heterosexual partner(s), vasectomy of partner at least 6 months prior to screening) or who have not been using hormonal birth control for a minimum of 3 months prior to study enrollment; * taking medication that alters gingival appearance or gingival bleeding (e.g., calcium channel blockers, anticonvulsants, or immunosuppressants) within one month prior to study initiation; * regularly (\>5x/week) using anti-gingivitis treatments (e.g., stannous fluoride toothpaste, or anti-gingivitis mouthwashes, such as those containing chlorohexidine) in the month prior to screening; * removable oral appliances; * fixed facial or lingual orthodontic appliances; * have a positive pregnancy test (clearblue) at baseline or self-reported pregnancy during the study; ; * any diseases or condition that might interfere with the safe participation in the study according to the study investigator; * inability to undergo study procedures; and * allergic reactions to any of the study toothpastes and/or ingredients in the study toothpastes.